Managers / Q4 2019 · view latest →
Spark Investment Management LLC
CIK 0001554871 · 150 EAST 58TH STREET, 26TH FLOOR, NEW YORK, NY, 10155 · 212-826-3709
Summary
Spark Investment Management LLC reported $853M in U.S.-listed holdings across 542 positions for Q4 2019.
Its largest position, ABBV, represents 2.0% of the portfolio.
Compared with Q3 2019, the fund opened 231 new positions and exited 82.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 95.2% · $812M
- Other · 4.8% · $41M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| DOOBRP INC | NEW | +154.0K | 154.0K | +$7M | $7M |
| FEFIRSTENERGY CORP | NEW | +140.5K | 140.5K | +$7M | $7M |
| SIRIUS XM HLDGS INC | NEW | +661.8K | 661.8K | +$5M | $5M |
| WELBILT INC | NEW | +301.9K | 301.9K | +$5M | $5M |
| CITRIX SYS INC | NEW | +39.3K | 39.3K | +$4M | $4M |
| REATA PHARMACEUTICALS INC | NEW | +18.5K | 18.5K | +$4M | $4M |
| VRRMVERRA MOBILITY CORP | NEW | +250.4K | 250.4K | +$4M | $4M |
| VRSNVERISIGN INC | NEW | +18.0K | 18.0K | +$3M | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $42M | 28 | May 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $40M | 27 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $40M | 20 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $36M | 23 | Aug 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $29M | 18 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $21M | 8 | Feb 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $17M | 9 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $17M | 11 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $18M | 13 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $17M | 11 | Feb 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $17M | 13 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $29M | 14 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $39M | 13 | May 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $46M | 14 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $52M | 25 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $69M | 28 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $104M | 27 | May 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $139M | 29 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $173M | 34 | Nov 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $182M | 43 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $149M | 43 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $121M | 54 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $72M | 52 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $27M | 87 | Aug 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $188M | 369 | May 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $853M | 542 | Feb 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $782M | 393 | Nov 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.4B | 549 | Aug 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $2.2B | 635 | May 7, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.